Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Disease Markers|October 24, 2015
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification StudySum-Fu Chiang, Chih-Yen Kan, Yung-Chin Hsiao, et al.Hepato-Gastroenterology|July 13, 2012
Concurrent chemoradiotherapy in the treatment of locally recurrent rectal cancerYau-Tong You, Jinn-Shiun Chen, Jeng-Yi Wang, et al.International Journal of Colorectal Disease|February 1, 2011
Surgical resection of locally advanced primary transverse colon cancer--not a worse outcome in stage II tumorHsin-Yuan Hung, Chien-Yuh Yeh, Chung-Rong Changchien, et al.International Journal of Colorectal Disease|April 12, 2011
Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapyHsin-Yuan Hung, Jinn-Shiun Chen, Chien Yuh Yeh, et al.Oncotarget|March 19, 2016
Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patientsHung-Chih Hsu, Tan Kien Thiam, Yen-Jung Lu, et al.Open Medicine (Warsaw, Poland)|September 21, 2022
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapyYu-Jen Hsu, Yih-Jong Chern, I-Li Lai, et al.Molecular Cancer Therapeutics|July 13, 2018
Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal CancerHung-Chih Hsu, Nina Lapke, Chuang-Wei Wang, et al.Cancers|July 2, 2021
A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative ResectionTzong-Yun Tsai, Jeng-Fu You, Yu-Jen Hsu, et al.World Journal of Surgical Oncology|December 11, 2019
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological riskI-Li Lai, Jeng-Fu You, Yih-Jong Chern, et al.Pageof 8